+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Diagnostic Electrocardiograph Market by Product (Devices, Software & Services), Lead Type (12-lead, 3-lead, 5-lead), End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4995133
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Diagnostic Electrocardiograph Market size was estimated at USD 10.50 billion in 2022, USD 11.20 billion in 2023, and is expected to grow at a CAGR of 6.68% to reach USD 17.61 billion by 2030.

A diagnostic electrocardiograph is a non-invasive, essential medical device used in detecting and monitoring heart-related diseases and conditions. Also referred to as an ECG or EKG, this device records the electrical activity of the heart over a period of time through electrodes attached to the skin. Globally, these devices are used in hospitals, clinics, and other healthcare facilities, with increased use in remote patient monitoring, a burgeoning trend in healthcare. Market expansion is propelled by the growing prevalence of cardiovascular ailments, advances in diagnostic technology, and the rise of remote patient monitoring. However, it faces challenges owing to the high cost of electrocardiographs and inadequate reimbursement policies for diagnostic devices. Future growth opportunities for the diagnostic electrocardiograph market lie in the growing adoption of digital health technology with the emerging applications of artificial intelligence and machine learning.

Regional Insights

Blended with innovation and lucrative opportunities, the diagnostic electrocardiograph market in the Americas is expected to grow substantially in the coming years. With the advent of crafted healthcare policies coupled with increased demand for non-invasive techniques and continuous technological advancements in electrocardiographs, this region holds a robust market stronghold. The Electrocardiograph market in the EMEA is gaining momentum, with the region’s increasing demand for advanced diagnostic tools, growing population, and rising health awareness. Europe's strong healthcare sector, paved by advanced disease management protocols, is driving the demand for accurate diagnostic devices including electrocardiographs. The markets in the Middle East and Africa are at a nascent stage but are expected to burgeon, primarily owing to the improving healthcare infrastructure and increased government intervention in healthcare digitalization. The Asia-Pacific (APAC) region, particularly the fast-growing economies of India and China, is creating lucrative opportunities for the diagnostic electrocardiograph market, with their vast patient base and increasing healthcare spending. Furthermore, the increasing prevalence of cardiovascular diseases coupled with the robust investment in advanced medical equipment are distinctive factors that are contributing to this upturn.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Diagnostic Electrocardiograph Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diagnostic Electrocardiograph Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Diagnostic Electrocardiograph Market, highlighting leading vendors and their innovative profiles. These include ACS Diagnostics, AliveCor, Inc., Ambu A/S, Aspel SA, ATsens Co., Ltd., Auxo Medical LLC, Bionet Co., Inc., BPL Medical Technologies Pvt. Ltd., BTL, Cardioline S.p.A., CompuMed, Inc., Custo Med GmbH, Davis Medical Electronics, Inc., Edan Instruments, Inc., Fukuda Denshi Co., Ltd., GE HealthCare Technologies Inc., Hill-Rom, Inc., Innomed Medical Zrt., Koninklijke Philips N.V., Lepu Medical Technology(Beijing)Co.,Ltd., Nihon Kohden Corporation, Norav Medical Ltd., OSI Systems, Inc., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Suzuken Co., Ltd., Vectracor, Inc., Viatom Technology Co., Ltd., VYAIRE Medical, Inc., and Zimmer MedizinSysteme GmbH.

Market Segmentation & Coverage

This research report categorizes the Diagnostic Electrocardiograph Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Devices
      • Event Monitors
      • Holter Monitors
      • Implantable Loop Recorders
      • Mobile Cardiac Telemetry Devices
      • Resting ECG Devices
      • Smart ECG Monitors
      • Stress ECG Devices
    • Software & Services
  • Lead Type
    • 12-lead
    • 3-lead
    • 5-lead
    • 6-lead
    • Single-lead
  • End User
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Diagnostic Electrocardiograph Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diagnostic Electrocardiograph Market?
  3. What are the technology trends and regulatory frameworks in the Diagnostic Electrocardiograph Market?
  4. What is the market share of the leading vendors in the Diagnostic Electrocardiograph Market?
  5. Which modes and strategic moves are suitable for entering the Diagnostic Electrocardiograph Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Diagnostic Electrocardiograph Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapidly Changing Lifestyles Increase the Incidence of Cardiovascular Diseases Worldwide
5.1.1.2. Surge in Global Aging Population and Need for Early Diagnosis of Cardiovascular Conditions
5.1.1.3. Increasing Development and Adoption of Wearable and Wireless Remote Monitoring Devices
5.1.2. Restraints
5.1.2.1. Issues with Unfavourable Reimbursement Policies
5.1.3. Opportunities
5.1.3.1. Emerging Demand from the Developing Economies with Improving Healthcare Infrastructure
5.1.3.2. Ongoing Advancements in Diagnostics with Increased Investments
5.1.4. Challenges
5.1.4.1. Lack of Skilled Expertise to Operate Advanced ECGs
5.2. Market Segmentation Analysis
5.2.1. Product: Growing utilization of software & services or data analysis and accurate interpretation
5.2.2. Lead Type: Growing preference for 12-lead electrocardiograph as it provides the most detailed diagnostics
5.2.3. End-User: Increasing potential of diagnostic electrocardiographs across hospitals & clinics with increased intensive care units and cardiac units
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Diagnostic Electrocardiograph Market, by Product
6.1. Introduction
6.2. Devices
6.3.1. Event Monitors
6.3.2. Holter Monitors
6.3.3. Implantable Loop Recorders
6.3.4. Mobile Cardiac Telemetry Devices
6.3.5. Resting ECG Devices
6.3.6. Smart ECG Monitors
6.3.7. Stress ECG Devices
6.3. Software & Services
7. Diagnostic Electrocardiograph Market, by Lead Type
7.1. Introduction
7.2. 12-lead
7.3. 3-lead
7.4. 5-lead
7.5. 6-lead
7.6. Single-lead
8. Diagnostic Electrocardiograph Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Centers
8.4. Hospitals & Clinics
9. Americas Diagnostic Electrocardiograph Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Diagnostic Electrocardiograph Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Diagnostic Electrocardiograph Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. AliveCor Collaborates with European Remote Patient Monitoring Company, Offering its 'Virtual Heart Clinic in a Box'
12.3.2. New Product Launch & Enhancement
12.3.2.1. UltraLinQ to Launch New Cardiac Monitoring Product at Arab Health
12.3.3. Investment & Funding
12.3.3.1. Acorai Wins EUR 2.3 Million Grant to Help Fund Trial for Heart Monitoring Device
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. ACS Diagnostics
13.1.2. AliveCor, Inc.
13.1.3. Ambu A/S
13.1.4. Aspel SA
13.1.5. ATsens Co., Ltd.
13.1.6. Auxo Medical LLC
13.1.7. Bionet Co., Inc.
13.1.8. BPL Medical Technologies Pvt. Ltd.
13.1.9. BTL
13.1.10. Cardioline S.p.A.
13.1.11. CompuMed, Inc.
13.1.12. Custo Med GmbH
13.1.13. Davis Medical Electronics, Inc.
13.1.14. Edan Instruments, Inc.
13.1.15. Fukuda Denshi Co., Ltd.
13.1.16. GE HealthCare Technologies Inc.
13.1.17. Hill-Rom, Inc.
13.1.18. Innomed Medical Zrt.
13.1.19. Koninklijke Philips N.V.
13.1.20. Lepu Medical Technology(Beijing)Co.,Ltd.
13.1.21. Nihon Kohden Corporation
13.1.22. Norav Medical Ltd.
13.1.23. OSI Systems, Inc.
13.1.24. Schiller AG
13.1.25. Shenzhen Comen Medical Instruments Co., Ltd.
13.1.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.1.27. Suzuken Co., Ltd.
13.1.28. Vectracor, Inc.
13.1.29. Viatom Technology Co., Ltd.
13.1.30. VYAIRE Medical, Inc.
13.1.31. Zimmer MedizinSysteme GmbH
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET RESEARCH PROCESS
FIGURE 2. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, 2022 VS 2030
FIGURE 3. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET DYNAMICS
FIGURE 7. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY LEAD TYPE, 2022 VS 2030 (%)
FIGURE 10. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY LEAD TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 12. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. DIAGNOSTIC ELECTROCARDIOGRAPH MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • ACS Diagnostics
  • AliveCor, Inc.
  • Ambu A/S
  • Aspel SA
  • ATsens Co., Ltd.
  • Auxo Medical LLC
  • Bionet Co., Inc.
  • BPL Medical Technologies Pvt. Ltd.
  • BTL
  • Cardioline S.p.A.
  • CompuMed, Inc.
  • Custo Med GmbH
  • Davis Medical Electronics, Inc.
  • Edan Instruments, Inc.
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare Technologies Inc.
  • Hill-Rom, Inc.
  • Innomed Medical Zrt.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • Nihon Kohden Corporation
  • Norav Medical Ltd.
  • OSI Systems, Inc.
  • Schiller AG
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Suzuken Co., Ltd.
  • Vectracor, Inc.
  • Viatom Technology Co., Ltd.
  • VYAIRE Medical, Inc.
  • Zimmer MedizinSysteme GmbH

Methodology

Loading
LOADING...

Table Information